β3-Adrenoceptors: a drug target in ophthalmology?
Authors:
- 24 January 2013
- journal article
- editorial
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 386 (4) , 265-267
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Specificity evaluation of antibodies against human β3-adrenoceptorsNaunyn-Schmiedeberg's Archives of Pharmacology, 2012
- Desirable properties of β3-adrenoceptor agonists: Implications for the selection of drug development candidatesEuropean Journal of Pharmacology, 2011
- Role of the Adrenergic System in a Mouse Model of Oxygen-Induced Retinopathy: Antiangiogenic Effects of β-Adrenoreceptor BlockadeInvestigative Ophthalmology & Visual Science, 2011
- Pharmacological evidence for the presence of functional β3-adrenoceptors in rat retinal blood vesselsNaunyn-Schmiedeberg's Archives of Pharmacology, 2010
- Relaxant effects of β-adrenoceptor agonist formoterol and BRL 37344 on bovine iris sphincter and ciliary muscleEuropean Journal of Pharmacology, 2006
- β3-Adrenergic receptors mediate choroidal endothelial cell invasion, proliferation, and cell elongationExperimental Eye Research, 2005
- Regulation of Vascular Endothelial Growth Factor by Oxygen in a Model of Retinopathy of PrematurityArchives of Ophthalmology (1950), 1996
- Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.Proceedings of the National Academy of Sciences, 1995
- Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agentJournal of Medicinal Chemistry, 1992
- Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugsNature, 1984